Texas AG suing generic drug makers
Pharma Compliance Alert, July 16, 2008
Makers of brand-name prescription drugs aren’t the only ones being accused of defrauding the government by artificially inflating the costs on medications.
Texas Attorney General Greg Abbott filed suit against generic manufacturers Watson/Schein Pharmaceuticals, Alpharma, Par Pharmaceutical, and Barr Pharmaceuticals, accusing them of charging too much for medication reimbursed by the state Medicaid agency, according to a release.
In the lawsuit, Abbott said the companies have been overpricing drugs since the 1990s resulting in windfall profits. The fraudulent pricing also unlawfully induced pharmacies and other providers to purchase the companies’ products.
The Texas AG’s office has a history of successfully settling pricing lawsuits. Schering-Plough/Warrick Pharmaceuticals in May 2004 ($27 million); Dey Inc. in June 2003 ($18.5 million); Boehringer Ingelheim/Roxane Laboratories in November 2005 ($10 million); and Baxter Healthcare Corp. in June 2006 ($8.5 million) previously settled pricing-fraud cases in Texas.
Comments
0 comments on “Texas AG suing generic drug makers ”
Related Products
-
ePharm5 InDepth
EPharm5 e-mail newsletter delivers the top 5 developments in pharma business innovation, with original research, interviews...
-
Big Pharma Performance Before, During and Beyond the Global Recession
This report assesses the performance of the leading 15 pharmaceutical companies up to, during and beyond the recent global...
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- QA:Coding multiple initial infusions
- Capturing all necessary codes for IUD insertion and removal can be challenging
- News and briefs: Oklahoma Osteopathic Association against residency bill change
- OB services: Coding inside and outside of the package
- HIPAA Q&A: Level of encryption needed for email
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- Joint Commission Center announces handoff communication solutions
- Inside best practice: Reduce patient falls with a stoplight
- Identify modifiable risk factors to prevent patient falls
- Hospitalist-surgeon comanagement has no effect on outcomes
- HIPAA Q&A: Level of encryption needed for email
- Case Management Monthly, June 2012
- Searched